SVB Leerink Downgrades Clementia Pharmaceuticals Inc. (CMTA) to Market Perform

February 26, 2019 5:18 AM EST Send to a Friend
SVB Leerink analyst Joseph Schwartz downgraded Clementia Pharmaceuticals Inc. (NASDAQ: CMTA) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login